text stringlengths 16 2.35k | tokenCount int64 5 450 | pageStart int64 1 43 | pageEnd int64 1 43 | hash stringlengths 64 64 |
|---|---|---|---|---|
Prevalence of functioning adrenal incidentalomas: a systematic review and meta-analysis. J Clin Endocrinol Metab . 2023;108(7):1813-1823. Seccia TM, Letizia C, Muiesan ML, et al . Atrial fibrillation as pre - senting sign of primary aldosteronism: | 76 | 38 | 38 | d02e04b8cf55263e13d5a7e96e16e3cd90473e71a891ea130b88997c4eb59512 |
results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study. J Hypertens . 2020;38(2):332-339. 2490 The Journal of Clinical Endocrinology & Metabolism , 2025, Vol. 110, No. | 68 | 38 | 38 | ea3981d5a8ce4cb82cbbc357960c440692dca69467f1b6fa49021d45b3018de1 |
9 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026 | 40 | 38 | 38 | 86d3541f16c4cf3f3990fa58d424f397068a88b4c212a690d7cd989da5201309 |
Murase K, Nagaishi R, Takenoshita H, Nomiyama T, Akehi Y, Yanase T. Prevalence and clinical characteristics of primary aldos - teronism in Japanese patients with type 2 diabetes mellitus and hypertension. | 54 | 39 | 39 | e3f9d4db39e71ab95067e729cc9f29400512a4695e18a57329b205ee1a5d1319 |
Endocr J . 2013;60(8):967-976. Hu Y, Zhang J, Liu W, Su X. Determining the prevalence of pri - mary aldosteronism in patients with new-onset type 2 diabetes and hypertension. | 56 | 39 | 39 | 617916d3fdd7d61ea2e558d181fe0d3982ee5849abdd1837c14995467b67e882 |
J Clin Endocrinol Metab . 2020;105(4): 1079-1085. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: | 69 | 39 | 39 | 38bc0d6c89580e0a08a37fc807fcae10ea5c7515306c4ec23922c52a948bf84d |
endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens . 2023;41(12):1874-2071. | 41 | 39 | 39 | e17e9f51a7899113df3beaab017bdaa34cb8e41eccc39f393c4c93b1c2a1292c |
Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev . 2018;39(6): 1057-1088. | 57 | 39 | 39 | 2fd8fc3d5f40401ea4376eda5cfe1bbca0b366bec6fdac067cc339f999bcd0d3 |
Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J. Guidelines for primary aldosteronism: uptake by pri - mary care physicians in Europe. J Hypertens . 2016;34(11): 2253-2257. | 63 | 39 | 39 | 0ab82fcb17ada8a4ef322aa15d527faf0dea77ffb8e56dbfae86f62e66df9431 |
Cohen JB, Cohen DL, Herman DS, Leppert JT, Byrd JB, Bhalla V. Testing for primary aldosteronism and mineralocorticoid receptor antagonist use among U.S. | 47 | 39 | 39 | 5b4718af4c35bd5ffb666efc071554d259f19f2f8668f840eb190c12e1c2ce24 |
Veterans: a retrospective cohort study. Ann Intern Med . 2021;174(3):289-297. Hundemer GL, Imsirovic H, Vaidya A, et al. | 41 | 39 | 39 | 343462e08cc9b0da44ea6cbd8224d6210e756195fd6f4e800273acb5a15eba39 |
Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study. Hypertension . 2022;79(1):178-186. Farah MH, Hegazi M, Firwana M, et al. | 58 | 39 | 39 | d8fb5c44660560e22b3ae29538330ab6dd62a94c8ddb6209f28728d826b64ccf |
A systematic review supporting the endocrine society clinical practice guideline on management of primary aldosteronism. J Clin Endocrinol Metab . 2025;110(9):e2833-e2844. Murad MH, Liem RI, Lang ES, et al. 2019 sickle cell disease guide - lines by the American Society of Hematology: methodology, chal - lenges, and inn... | 247 | 39 | 39 | 7b8b108b7df8a55160701bf7b860816d3ae8a50d643b15f5e974343fc7f9c07f |
Clinical and genetic cor - relates of aldosterone-to-renin ratio and relations to blood pres - sure in a community sample. Hypertension . 2007;49(4):846-856. Brown JM, Robinson-Cohen C, Luque-Fernandez MA, et al. The spectrum of subclinical primary aldosteronism and incident hyper - tension: a cohort study. Ann Intern ... | 99 | 39 | 39 | 5269c0955fde7aa07c1e80539118ab475e6583bf9964f7b925b47b123655e5dc |
Meneton P, Galan P, Bertrais S, Heudes D, Hercberg S, Ménard J. High plasma aldosterone and low renin predict blood pressure in - crease and hypertension in middle-aged Caucasian populations. | 52 | 39 | 39 | 1f1da7570c16919b45d270df83e4b85dcea2859a23d65064be95d5ef5692b993 |
J Hum Hypertens . 2008;22(8):550-558. Arnold N, Hermanns IM, Schulz A, et al. Renin, aldosterone, the aldosterone-to-renin ratio, and incident hypertension among normotensive subjects from the general population. | 61 | 39 | 39 | 354f011228d39941714c151fce383a95dd41941ee3808cb7adc1662b0316fbc1 |
Cardiovasc Res . 2023;119(1):294-301. Hu J, Shen H, Huo P, et al. Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: | 57 | 39 | 39 | 6c3a7637763bbe989664e8c7a746fcd28ea7bed92e7ad68b00f0e4df0e713c25 |
a collaborative study. J Am Heart Assoc . 2021;10(24):e023082. Lieb W, Larson MG, Benjamin EJ, et al. Multimarker approach to evaluate correlates of vascular stiffness: the Framingham heart study. Circulation . 2009;119(1):37-43. Hundemer GL, Agharazii M, Madore F, et al. Subclinical primary aldosteronism and cardiovas... | 193 | 39 | 39 | 91f6274486c4d242d3af27d7611b4840487d6279008d4c0253cbf812b3d51645 |
Relationship between renin, aldosterone, aldosterone-to-renin ratio and arterial stiffness and left ventricular mass index in young adults. Circulation . 2024; 150(25):2019-2030. Liu YY, King J, Kline GA, et al. | 61 | 39 | 39 | f03de7d8d569c9daf7b29e550adb0a1af12d89d801dcaac80f86cd5444b52858 |
Outcomes of a specialized clinic on rates of investigation and treatment of primary aldosteronism. JAMA Surg . 2021;156(6):541-549. Yang J, Fuller PJ, Stowasser M. Is it time to screen all patients with hypertension for primary aldosteronism? Med J Aust . 2018; 209(2):57-59. Wu VC, Wang SM, Huang KH, et al. | 90 | 39 | 39 | f9bbaf4697fb4326de969545f14acda5a14b045db772ee5db53f644558066583 |
Long-term mortality and car - diovascular events in patients with unilateral primary aldosteronism after targeted treatments. Eur J Endocrinol . 2021;186(2):195-205. Sato M, Morimoto R, Seiji K, et al. | 56 | 39 | 39 | 6beb5f3ca0ba0e45f90200188a6a75290e1ea04e6cb4d0699de6476f61e4aba0 |
Cost-effectiveness analysis of the diagnosis and treatment of primary aldosteronism in Japan. Horm Metab Res . 2015;47(11):826-832. Li N, Huang J, Zheng B, Cai H, Liu M, Liu L. Cost-effectiveness analysis of screening for primary aldosteronism in China. Clin Endocrinol (Oxf) . 2021;95(3):414-422. Woode ME, Wong K, Reid... | 128 | 39 | 39 | c617b22151e30592b254ad017bb618b9d348294b424cb5a87d9d161c2d498306 |
a markov modelling analysis. J Hypertens . 2023; 41(10):1615-1625. Nainani AK, Yang J, Peters S, Russell G. ‘ I can ’ t understand why others don ’ t screen more ’ : a qualitative study exploring why Australian general practitioners screen for primary aldosteronism. BMJ Open . 2022;12(6):e061671. Ananda RA, Gwini SM, L... | 155 | 39 | 39 | 07ba75e724e91761a1945701c134860c4a31f077add1afab83f2331628b44113 |
Performance of the aldosterone-to-renin ratio as a screening test for primary aldoster - onism in primary care. Endocrine . 2022;77(1):11-20. | 41 | 39 | 39 | 7af455e547b54e963834311c286b27ad815c6a213ecf3283eceef21c35afb25a |
Shah SS, Zhang J, Gwini SM, Young MJ, Fuller PJ, Yang J. Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: | 43 | 39 | 39 | 518890bfe6327e0c9ce200c5b89dec40694a0129bc9d163bc25d9d0bf71ced58 |
a systematic review and meta-analysis. J Hum Hypertens . 2024;38(5):383-392. Buffolo F, Pecori A, Reincke M, et al. | 41 | 39 | 39 | 40b953a876228952559e229a81865c4749efc4eb86cbd239617ae18dfa687d4b |
Long-term follow-up of pa - tients with elevated aldosterone-to-renin ratio but negative con - firmatory test: the progression of primary aldosteronism phenotypes. Hypertension . 2024;81(2):340-347. | 56 | 39 | 39 | 031dce636fa141ad9218746fbf41231bbfd0317b15dbd78a7a85eb95de7d59d9 |
Martinez-Aguayo A, Aglony M, Campino C, et al. Aldosterone, plasma renin activity, and aldosterone/renin ratio in a normotensive healthy pediatric population. | 46 | 39 | 39 | 466a1502d542776810e4c911a84cff11809162ee9165ac58609e610203193227 |
Hypertension . 2010;56(3):391-396. Genovesi S, Antolini L, Orlando A, et al. Aldosterone-to-renin ra - tio depends on age and sex in children attending a clinic for cardio - vascular risk assessment. | 57 | 39 | 39 | 0b0ba4b2000f8b3df571fc6a74dd7ec1e53ae00118a4fcced8f8e74dd77100e4 |
J Hypertens . 2018;36(2):344-352. Forestiero V, Sconfienza E, Mulatero P, Monticone S. Primary al - dosteronism in pregnancy. Rev Endocr Metab Disord . 2023; 24(1):39-48. Monticone S, Auchus RJ, Rainey WE. Adrenal disorders in preg - nancy. Nat Rev Endocrinol . 2012;8(11):668-678. Eisenhofer G, Durán C, Cannistraci CV,... | 121 | 39 | 39 | 4f99b057ff0ecb039c7634d5fa36a3a7dce6fb515a58988bccce687289625cdf |
Use of steroid pro - filing combined with machine learning for identification and sub - type classification in primary aldosteronism. JAMA Netw Open . 2020;3(9):e2016209. Reel PS, Reel S, van Kralingen JC, et al. Machine learning for classi - fication of hypertension subtypes using multi-omics: a multi-centre, retrospe... | 180 | 39 | 39 | cc7f40316fb4fc8ae95ae700cbda1821b0def704e973d071d1deba31119f19b3 |
Subtype diagnosis, treatment, complications and outcomes of primary The Journal of Clinical Endocrinology & Metabolism , 2025, Vol. 110, No. 9 2491 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026 | 73 | 39 | 39 | 1838192c4036080569f51ba73a95498abf0788ee36eb37cc39d61b9f7af54e1b |
aldosteronism and future direction of research: a position state - ment and consensus of the working group on endocrine hyperten - sion of the European Society of Hypertension. J Hypertens . 2020; 38(10):1929-1936. Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldoster... | 86 | 40 | 40 | 43fc8186565584bfa2f17d85dbd1e7ff330aaf7b64a692a8eb3cc2f6f18029e5 |
an inter - national consensus on outcome measures and analysis of remis - sion rates in an international cohort. Lancet Diabetes Endocrinol . 2017;5(9):689-699. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med . 2008;168(1):80-85. Mu... | 101 | 40 | 40 | e224ebb06694dbd5df44dfc326d52022df3325559deda930e57faf76f89e63fe |
Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab . 2013;98(12):4826-4833. Williams TA, Burrello J, Sechi LA, et al. | 56 | 40 | 40 | aa67b922a528d3c70d605308df25e313890918d7aa87268493d6190e5b655525 |
Computed tomography and adrenal venous sampling in the diagnosis of unilateral pri - mary aldosteronism. Hypertension . 2018;72(3):641-649. Mulatero P, Stowasser M, Loh KC, et al. | 56 | 40 | 40 | e05f19045ae57eb8c5ead9b82ad128cfd699e38b6dc60edae508bde9527bfe01 |
Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab . 2004; 89(3):1045-1050. | 43 | 40 | 40 | 54cededcf74619f07952ac38257af3c049cf85415a01f715659a076e3d893bb2 |
Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hyperten - sive patients: | 49 | 40 | 40 | 8b11d87d1300edceff401a0d1178cc242c897aea3a2290d9237b17c28cacdcef |
a prospective study based on the use of an aldoster - one/renin ratio above 25 as a screening test. Hypertens Res . 2007; 30(2):111-117. Kubo H, Tsurutani Y, Inoue K, et al. | 58 | 40 | 40 | 6b6dab9f8323e284b973eba21f0d19400fab3c42ff53d74bdc54ca06d0607a39 |
Characteristics of aldosterone-producing adenomas in patients without plasma re - nin activity suppression. PLoS One . 2022;17(4):e0267732. Li X, Goswami R, Yang S, Li Q. | 49 | 40 | 40 | feeecf93bc0642f6b6d89bb5a503d5a50b42ffb3c6b46a507270f59eb0852ec9 |
Aldosterone/direct renin concen - tration ratio as a screening test for primary aldosteronism: a meta- analysis. J Renin Angiotensin Aldosterone Syst . 2016;17(3): 1470320316657450. Maciel AAW, Freitas TC, Fagundes GFC, et al. | 75 | 40 | 40 | 60a9a4a2a60939c3551e2751f7e1953a28849426a28edb2db8ac4447207bf456 |
Intra-individual variability of serum aldosterone and implications for primary al - dosteronism screening. J Clin Endocrinol Metab . 2023;108(5): 1143-1153. Liu Z, Deng X, Luo L, et al. | 55 | 40 | 40 | b01642d1c5d0545175e43e90b81b7a2c92d7a38b1033a46621342dfc77df2e54 |
Diagnostic value of aldosterone to re - nin ratio calculated by plasma renin activity or plasma renin con - centration in primary aldosteronism: a meta-analysis. Chin Med J (Engl) . 2022;135(6):639-647. | 59 | 40 | 40 | 122f5bd96cec4a7551c1de338317337fc8b2707ab978ae6b38737d66556aab30 |
Suntornlohanakul O, Sakarin S, Kietsiriroje N, Sriplung H. Geographical inequality in service utilization for primary aldoster - onism screening: spatial epidemiological study in southern Thailand. BMC Health Serv Res . 2022;22(1):458. Nainani A, Russell G, Yang J, Peters S. | 76 | 40 | 40 | 8c667dc9c19a691dbe4d734b06c91e6a667a171085cc5d5155cc4f178ee0f1dc |
General practitioner per - spectives and experiences when screening for primary aldosteron - ism in hypertensive patients. Ann Fam Med . 2022;20(20 Suppl 1): 3178. Li X, Liang J, Hu J, et al. Screening for primary aldosteronism on and off interfering medications. Endocrine . 2024;83(1):178-187. Pilz S, Keppel MH, Trumm... | 95 | 40 | 40 | df5f02f350f6a96c7ec008016199d1889b92458809ad6657288dea6cde870020 |
Diagnostic accuracy of the aldosterone-to-active renin ratio for detecting primary aldosteron - ism. J Endocr Soc . 2019;3(9):1748-1758. Stowasser M, Ahmed AH, Cowley D, et al. | 59 | 40 | 40 | fc563c987e55e0395a8cf3f2ead216ecb03638015a513b8040454e96bb3e9dc7 |
Comparison of seated with recumbent saline suppression testing for the diagnosis of pri - mary aldosteronism. J Clin Endocrinol Metab . 2018;103(11): 4113-4124. Guo Z, Poglitsch M, McWhinney BC, et al. | 63 | 40 | 40 | 227f0960058ecab174486a4d433be28bb5e940e8dcc21adce93b8ec24744ee9f |
Aldosterone LC-MS/ MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. J Clin Endocrinol Metab . 2018;103(11):3965-3973. Thuzar M, Young K, Ahmed AH, et al. | 61 | 40 | 40 | 7eb5e3c025c03b7961a9e283affeef9f66bf89cf4305a6dddbf0a41b32edf79b |
Diagnosis of primary al - dosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS/MS. J Clin Endocrinol Metab . 2020;105(3):e477-e483. | 52 | 40 | 40 | 7efd0bad62933262152d1d2677ae1e9f4014c54e5c414340bda02d73d5136c48 |
Brown JM, Auchus RJ, Honzel B, Luther JM, Yozamp N, Vaidya A. Recalibrating interpretations of aldosterone assays across the physiologic range: | 42 | 40 | 40 | 55f8d8fb201155e1ba99ff84ca5d87695d76f0ae703ef9594f193f5cb8e35b4e |
immunoassay and liquid chromatography- tandem mass spectrometry measurements under multiple con - trolled conditions. J Endocr Soc . 2022;6(6):bvac049. | 41 | 40 | 40 | b1cc69a1e223d1960080b3d3ae720faf204d907a60c128a137b418065e3433b5 |
Vaidya A, Morlote M, Moussa M, Barletta J, Nehs M. Targeting a hormonal cause of hypertension. N Engl J Med . 2025;392(4): Eisenhofer G, Kurlbaum M, Peitzsch M, et al. The saline infusion test for primary aldosteronism: implications of immunoassay in - accuracy. J Clin Endocrinol Metab . 2022;107(5):e2027-e2036. Leung ... | 216 | 40 | 40 | 7cb16e64f6292ed780de3de0ccffe8dd05dc466c83eec5ab385e07bfc9f4989b |
Kline GA, Pasieka JL, Harvey A, So B, Dias VC. High-probability features of primary aldosteronism may obviate the need for con - firmatory testing without increasing false-positive diagnoses. | 52 | 40 | 40 | df1d38a1cbd1e52d4ad16849560ae5f25e9336d82886e685cefdb888c05420b8 |
J Clin Hypertens (Greenwich) . 2014;16(7):488-496. Mulatero P, Monticone S, Deinum J, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: | 52 | 40 | 40 | 589f7eb64578514c14ec72cd915253cf1b2cedbf6f2e054b7938d67d5570e447 |
a position statement and consensus of the working group on endocrine hyper - tension of the European Society of Hypertension. J Hypertens . 2020;38(10):1919-1928. Naruse M, Katabami T, Shibata H, et al. | 57 | 40 | 40 | d1e26133b8e9ad57f9a12f40e51d57c7d1234ba121fbdca5df5dafa6ed87d517 |
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J . 2022;69(4):327-359. Morera J, Reznik Y. MANAGEMENT OF ENDOCRINE DISEASE: | 55 | 40 | 40 | 075dff6c5d0c51d7e205515fa0ac962ec2dda005329fc4d242cc7f7ff28187ef |
the role of confirmatory tests in the diagnosis of pri - mary aldosteronism. Eur J Endocrinol . 2019;180(2):R45-R58. Song Y, Yang S, He W, et al. Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study. Hypertension . 2018;71(1):118-124. Ahmed AH, Cowley D, Wolley M, et al... | 200 | 40 | 40 | 4922bc18613bc5788679a193b3b2852708890a379e6c3d65e60ef8c98841e73f |
Treatment of primary al - dosteronism and reversal of renin suppression improves left ven - tricular systolic function. Front Endocrinol (Lausanne) . 2022; 13:916744. Velema M, Dekkers T, Hermus A, et al. Quality of life in primary al - dosteronism: a comparative effectiveness study of adrenalectomy and medical treatme... | 121 | 40 | 40 | b5458288a3b9fe263aced4bbece15a8e21150da509d611e2d2494cf4c9475836 |
Adrenal vein sampling ver - sus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol . 2016;4(9):739-746. Pan CT, Liao CW, Tsai CH, et al. | 62 | 40 | 40 | b6d648f999d91deaa422e7de21e227310bdfae030e8dc557d0c88fb5f41c2062 |
Influence of different treatment strategies on new-onset atrial fibrillation among patients with pri - mary aldosteronism: a nationwide longitudinal cohort-based study. J Am Heart Assoc . 2020;9(5):e013699. | 54 | 40 | 40 | 30d4ab580558e0df9ed2f53d68e8f312c330598cbf1bf9eeb005a4bde5b94f18 |
Jeunemaitre X, Chatellier G, Kreft-Jais C, et al. Efficacy and toler - ance of spironolactone in essential hypertension. Am J Cardiol . 1987;60(10):820-825. Tang F, Loh LM, Foo RS, et al. Tolerability and efficacy of long- term medical therapy in primary aldosteronism. J Endocr Soc . 2021;5(11):bvab144. Bernini G, Bacc... | 118 | 40 | 40 | 6d470ba696cf2168d6f86d115883b67ad153f9abdc37b22dc1ca532574d6b51f |
Cardiovascular changes in pa - tients with primary aldosteronism after surgical or medical treat - ment. J Endocrinol Invest . 2012;35(3):274-280. Parthasarathy HK, Ménard J, White WB, et al. | 56 | 40 | 40 | 24242871e20474e9e43982ebe3781a2307f1bfecc37bd0c695e7251dff0e7ccb |
A double-blind, randomized study comparing the antihypertensive effect of eplere - none and spironolactone in patients with hypertension and evi - dence of primary aldosteronism. | 44 | 40 | 40 | bc2c76e3599d60bc1716f8ff4172abefa181e047205e94aabc2fc762e1f660d9 |
J Hypertens . 2011;29(5):980-990. Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease 2492 The Journal of Clinical Endocrinology & Metabolism , 2025, Vol. | 65 | 40 | 40 | 81a83fbe1ad82cdc0cbab72a8cdc32fc69a24d7a7a130c9a4ef4e5b543883c93 |
110, No. 9 Downloaded from https://academic.oup.com/jcem/article/110/9/2453/8196671 by University of Wisconsin System user on 20 February 2026 | 44 | 40 | 40 | 838dd5eb379613452959448b60e11bc1b5cf46655c5056a0432c7ee39628472d |
after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab . 2014;99(5):1593-1598. Lubitz CC, Economopoulos KP, Sy S, et al. | 50 | 41 | 41 | 6575ee928f96b2e745d97ea13846dd47c62f2acf09d0cbcacecf192b2cabc11d |
Cost-effectiveness of screening for primary aldosteronism and subtype diagnosis in the resistant hypertensive patients. Circ Cardiovasc Qual Outcomes . 2015;8(6):621-630. Reimel B, Zanocco K, Russo MJ, et al. | 59 | 41 | 41 | bde4073ccbeaeca689d1548ba7d06078b14db44eb11af3402e69be17a710e9be |
The management of aldosterone-producing adrenal adenomas — does adrenalectomy in - crease costs? Surgery . 2010;148(6):1178-1185; discussion 1185. Hawkins NM, Scholes S, Bajekal M, et al. Community care in England: reducing socioeconomic inequalities in heart failure. Circulation . 2012;126(9):1050-1057. | 85 | 41 | 41 | d30d6e091cdcdef9f4095b2af66acca18593d3c3248d8e40605adaa018ef0801 |
Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient noncompliance? Hypertension . 1980;2(6):757-764. Lachaine J, Beauchemin C, Ramos E. | 61 | 41 | 41 | e11cb0b2cd7b457b8ff1d52eafd73e84ee47f887a830af1783a9a82357335c3c |
Use, tolerability and compli - ance of spironolactone in the treatment of heart failure. BMC Clin Pharmacol . 2011;11(1):4. Nikrýnová Nguyen TMP, Štrauch B, Petrák O, et al. | 60 | 41 | 41 | fa3eefe4d956de931d8d6ad149faddd528ff8132818bea8ace52759ed5cae001 |
Adherence and blood pressure control in patients with primary aldosteron - ism. Blood Press . 2022;31(1):58-63. Ginzberg SP, Gasior JA, Kelz LA, et al. Adrenalectomy approach and outcomes according to surgeon volume. Am J Surg . 2024;229: 44-49. | 71 | 41 | 41 | de79be122deef9486145931bb1fcbcf3e7d66907561f7e82c624f101c870be7a |
Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of uni - lateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab . 2009;94(7): 2437-2445. Williams TA, Gong S, Tsurutani Y, et al. Adrenal surgery for bi - lateral primary aldosteronism: an international ... | 121 | 41 | 41 | 5358c466a7f12cf2559b6c81a04c31de61c8ee933c7ccae94f8f14942b7d106b |
Szabo Yamashita T, Shariq OA, Foster TR, et al. Unilateral adre - nalectomy for primary aldosteronism due to bilateral adrenal dis - ease can result in resolution of hypokalemia and amelioration of hypertension. | 60 | 41 | 41 | 036a65d652aee9d7bdcd58c41ba811441c613baec807d006a5bddea50f49cb89 |
World J Surg . 2023;47(2):314-318. Kempers MJ, Lenders JW, van Outheusden L, et al. Systematic re - view: | 41 | 41 | 41 | d704d36d6df1343661ee8cfe3c6aa4680921a4edecc78ebf969f0ad7e1f60d07 |
diagnostic procedures to differentiate unilateral from bilat - eral adrenal abnormality in primary aldosteronism. Ann Intern Med . 2009;151(5):329-337. Lim V, Guo Q, Grant CS, et al. | 51 | 41 | 41 | d984208f30147ba7536426a08e066004e61a328e0a3cc6d932679e99bbd229cd |
Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary al - dosteronism. J Clin Endocrinol Metab . 2014;99(8):2712-2719. Ma D, Liu X, Zeng L, et al. | 58 | 41 | 41 | 0ed5be1730aa09823b7dd4e1d4c466dbf7cbe852582c98534943035e583b8130 |
The role of adrenal venous sampling and computed tomography in the management of primary aldos - teronism. J Hypertens . 2021;39(2):310-317. | 40 | 41 | 41 | 9f546ca3af745c92cacb32bea18d4a4a0519ae9265bd33b0bec3ab44ad7bee45 |
Gkaniatsa E, Sakinis A, Palmér M, Muth A, Trimpou P, Ragnarsson O. Adrenal venous sampling in young patients with primary aldosteronism. Extravagance or irreplaceable? J Clin Endocrinol Metab . 2021;106(5):e2087-e2095. Thiesmeyer JW, Ullmann TM, Stamatiou AT, et al. | 94 | 41 | 41 | 0114ad146564e92a735f5bb00a5b6778f06fb6687af046d5de4e3b8f352005c2 |
Association of adrenal venous sampling with outcomes in primary aldosteronism for unilateral adenomas. JAMA Surg . 2021;156(2):165-171. Fang C, Dai J, Zhao J, et al. | 50 | 41 | 41 | 78e3ac3f700764ee418be8bd62ae1b9cc90ee088604561cce18137e3e91ad500 |
Surgery based on computed tomog - raphy images might be feasible for primary aldosteronism patients with visible unilateral adenoma. J Clin Hypertens (Greenwich) . 2023;25(11):1001-1008. Rossi GP, Barisa M, Allolio B, et al. | 66 | 41 | 41 | da015ca9fe759bf99e627534c79020ab1b0350245e058a3afa41718288a83004 |
The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab . 2012;97(5): 1606-1614. Young WF, Stanson AW. | 53 | 41 | 41 | b42ca2f3c847527e14303a7d4db77dba3505cd2666f41df3056c4f8f885ed58f |
What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) . 2009;70(1):14-17. | 44 | 41 | 41 | 1a7cb529703a10a3abfd057c7b639a2cb5e5fecd56d61d363eeaea0c6aa1e554 |
Arjani S, Bostonian TJ, Prasath V, Quinn PL, Chokshi RJ. Cost-effectiveness of adrenal vein sampling- vs computed tomography-guided adrenalectomy for unilateral adrenaloma in pri - mary aldosteronism. | 57 | 41 | 41 | 498b51af25bd61dcf85c9cc30c6ae4973eeaa5e847ce93fdf413bb1cb66c433c |
J Endocrinol Invest . 2022;45(10):1899-1908. Vonend O, Ockenfels N, Gao X, et al. Adrenal venous sampling. Hypertension . 2011;57(5):990-995. Mohan S, Shariq OA, Andrews JC, Young WF Jr. | 73 | 41 | 41 | 9d34767d796655654ccd52b322324bba8b72aadcc8ed96280169513ecf15aee9 |
Effect of cor - ticosteroid premedication on adrenal vein sampling in patients with primary aldosteronism and iodinated contrast media allergy. J Vasc Interv Radiol . 2025;36(4):594-600. Rossi GP, Auchus RJ, Brown M, et al. | 64 | 41 | 41 | eaf0f3118239e367dfef78e8a3a61371bdd2bf3521daf8043d67321aeb5d0405 |
An expert consensus state - ment on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension . 2014;63(1):151-160. | 40 | 41 | 41 | 4c624b97597ba74fa71c1cb106a803f6c1932c894ea7b4a66f6c2688d91ecf64 |
Carr CE, Cope C, Cohen DL, Fraker DL, Trerotola SO. Comparison of sequential versus simultaneous methods of adrenal venous sampling. J Vasc Interv Radiol . 2004;15(11): 1245-1250. Elliott P, Holmes DT. Adrenal vein sampling: substantial need for technical improvement at regional referral centres. Clin Biochem . 2013;46... | 107 | 41 | 41 | f6acfa65bf07ff09c80224de87218b9c0fb15edc3aca51972dc8ed5e9379a807 |
Effect of adrenocortico - tropic hormone stimulation during adrenal vein sampling in pri - mary aldosteronism. Hypertension . 2012;59(4):840-846. | 42 | 41 | 41 | c038d7e71aaa5fc66e367ca503e2e1cdce0b5fdae2568cabae442d4c0ad027ce |
Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary al - dosteronism. Surgery . 2004;136(6):1227-1235. | 54 | 41 | 41 | 6ea62aa90b4d98baf80a3d96029ee631f1b42a7d8971ddd47e6a2b2c4a00302a |
Rossi GP, Battistel M, Seccia TM, Rossi FB, Rossitto G. Subtyping of primary aldosteronism by adrenal venous sampling. Endocr Rev . 2025;163:789-795. Rossitto G, Amar L, Azizi M, et al. Subtyping of primary aldoster - onism in the AVIS-2 study: assessment of selectivity and lateraliza - tion. J Clin Endocrinol Metab . ... | 128 | 41 | 41 | 3412619b9a31b564f5448cc9bbb04c6fece30e16598e0ae91eb80aeaa7d3bec8 |
Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronism. Best Pract Res Clin Endocrinol Metab . 2020; 34(3):101400. Zhou Y, Zhang H, Luo J, et al. | 55 | 41 | 41 | 6a23f223ca2ecd0aaf7452d01bccf83b0b3cdb6ed146dbf967cfa49b0c0fc309 |
Intraprocedural cortisol measure - ment increases adrenal vein cannulation success rate in primary al - dosteronism: a systematic review and meta-analysis. Am J Hypertens . 2024;37(2):134-142. Yozamp N, Hundemer GL, Moussa M, et al. | 67 | 41 | 41 | 9565131ff087021fcf0dcf174697d7f5736fdf9b5796e0f8396b86053c9ecb1a |
Intraindividual variability of aldosterone concentrations in primary aldosteron - ism: implications for case detection. Hypertension . 2021;77(3): 891-899. Takeda Y, Umakoshi H, Takeda Y, et al. | 58 | 41 | 41 | 69a16a4b0809169294b2ac4b3d9357a22765b83ef5cc5b8e082a65af6762fb2d |
Impact of adrenocortico - tropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism. J Hypertens . 2019;37(5): 1077-1082. Yatabe M, Bokuda K, Yamashita K, et al. | 62 | 41 | 41 | 3329440ee1bf7c6b0c77580c7caf1ef9ee8c809ac2db42863ba22c56ac42a193 |
Cosyntropin stimula - tion in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism. Hypertens Res . 2020;43(10):1105-1112. Okubo J, Frudit P, Cavalcante A, et al. | 70 | 41 | 41 | e9ca968c4cdfa0ec026a4602adf4e85f5fec43ded22890f8c61a08045355068c |
Contralateral suppression in adrenal venous sampling predicts clinical and biochemical out - come in primary aldosteronism. J Clin Endocrinol Metab . 2024; 109(9):2282-2293. | 45 | 41 | 41 | 90e7c2b4345a8020cfe99e5dbc90cdc3f8b4abb39cfb090ae1d4c26ceaceb361 |
Desrochers MJ, St-Jean M, El Ghorayeb N, et al. Basal contralat - eral aldosterone suppression is rare in lateralized primary aldos - teronism. | 46 | 41 | 41 | 3070ea02d5487d8e37fb60b01827d45a697c3b713f94fa77131e44565e4e2d85 |
Eur J Endocrinol . 2020;183(4):399-409. Nanba AT, Wannachalee T, Shields JJ, et al. Adrenal vein sam - pling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism. | 60 | 41 | 41 | a16b91cc7d32eae670c20106a4546f1489da86a1ab34781685e76ffb0d237001 |
J Clin Endocrinol Metab . 2019;104(2):487-492. Pintus G, Seccia TM, Amar L, et al. Subtype identification of sur - gically curable primary aldosteronism during treatment with min - eralocorticoid receptor blockade. | 64 | 41 | 41 | b6040fd2e09b51cfbb7658baab6e6fee997a3a2e53fc1f9167440d52297a6b71 |
Hypertension . 2024;81(6): 1391-1399. Jing Y, Hu J, Luo R, et al. Prevalence and characteristics of adrenal tumors in an unselected screening population: a cross-sectional study. Ann Intern Med . 2022;175(10):1383-1391. Umakoshi H, Ogasawara T, Takeda Y, et al. | 85 | 41 | 41 | 2f98e36e8b042f3b11032b4a829c7e4dea0fd38ca3586b6e26a45f913725f662 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.